Simple urine test may predict kidney recovery after acute failure
NCT ID NCT02889575
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 287 patients with acute kidney injury caused by tubular necrosis. Researchers measured two substances in urine (PIIINP and NGAL) to see if they could predict whether kidney function would return or if chronic kidney disease would develop. The goal is to find a simple test that helps doctors make better treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple urine test that helps doctors predict which patients will recover kidney function and which will develop long-term kidney failure.
- What could go wrong
- This is an observational study, not a treatment trial. The biomarkers may not prove accurate enough for routine use, and results may not apply to all kidney injury patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
287 people
The number who actually took part.
- Start date
-
Apr 2012
- Finished
-
Feb 2016
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients experimenting ARF in ATN context.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * off-age patient. * ATN diagnosis based on 1) typical clinical environment (sepsis, nephrotoxicity...) 2) 50% decrease of glomerular filtration flow (according clearance MDRD) or more than 100micromol plasmatic creatinine increase. 3) no renal function improvement after efficient vascular filling (\>750cc normal saline or equivalent). * Consent. Exclusion Criteria: * ARF not related with ATN context. * Life expectancy less than 3 months. * Protocol refusal
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute kidney tubular necrosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nantes
Nantes, 44093, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can matching contrast dye to your actual kidney capacity prevent Scan-Related kidney damage?
- Can dialysis filters improve kidney recovery? a data review seeks answers
- Why kidney patients feel so tired: muscle fatigue under the microscope
- Contrast dye test reveals hidden kidney damage in ICU survivors
- Alcohol lock may stop deadly infections in ICU patients
- Can a simple breath test protect dialysis Patients' brains?